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Case report
SIGNET RING CELL ADENOCARCINOMA IN A URACHAL CYST-A RARE CASE
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ABSTRACT
Adenocarcinoma arising in   anurachal cyst is extremely rare. This paper describes a patient who came with chief
complaints of hematuria, was treated with partial cystectomy for urachal cyst, and the pathologic examination
revealed urachal adenocarcinoma of signet ring cell type in the urachal cyst.
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INTRODUCTION
The  urachus  is  a  remnant  of  the  primitive  bladder
dome and extends from the anterior dome of bladder
towards the umbilicus. It exists as vestigial part of the
two embryonic structures, the cloaca, from urogenital
sinus and allantois, which is derivative of yolk sac
1.
Many anomalies of the urachus remnants have been
reported  like  urachal  cyst,  urachal  fistula,  umbilical
urachal  sinus,  vesicourachal  diverticulum  and  very
rarely adenocarcinoma of urachus
.2.We hereby report a
case  of  signet  ring  cell  adenocarcinoma  in  aurachal
cyst with fewer than 300 cases reported in literature.
CASE REPORT
A 57yrs old female patient was admitted in November
2013with  chief  complaints  of  hematuria  and  clots
since 20 days. There was no evidence of abdominal
pain or distension. Laboratory investigations revealed
normal  renal  function  tests  and  serum  electrolytes.
Urine  cytology  was  normal.  The  patient  underwent
ultrasound  scan  which  suggested  complex
diverticulum and raised a doubt of urachal cyst. On CT
scan a complex cystic lesion was noted anterior to the
dome of bladder with thin lateral septations and foci of
calcification.  The diagnosis  was  confirmed  by
cystoscopy  and  partial  cystectomy  with  resection  of
urachal  cyst  and umbilicus.  The gross  examination
revealed a single globular cystic mass with an attached
flap of urinary bladder with fragment of skin covered
tissue (umbilicus).There was no communication seen
between the bladder and the attached cystic mass. Cut
section showed multiloculated cyst filled by gelatinous
material  (Fig  l).  Microscopic  studies  showed
malignant epithelial tumour withtumour cellsarranged
in  glandular  pattern,  lakes  of  mucin  and  signet ring
cells (Fig2). The tumour was confined to urachal cyst
with surgical margins free from tumour. Clinically and
histopatholgically the disease was proposed as stage II.
Chest  x  ray  andultrasound  scan  did  not  reveal  any
evidence  of  distant metastasis.  Postoperative period
was uneventful and tumour markers such as CEA   and
CA19 levels were normal.
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Fig 1: Urachal cyst filled with gelatinous material
Fig 2: Signet ring cells floating in mucinous lake
DISCUSSION
Urachal  cyst  is  also  known  as a  median  umbilical
ligament.  Urachal  cysts  are  sequale  of  remnants  of
vestigial structure connecting allantois to the bladder
apex.  Urachal  adenocarcinoma  is  extremely  rare.
Adenocarcinomatous change in such cystic remnants
accounts  for  0.17-0.34%  of  bladder  cancers
3and  20-
30%  of  primary  adenocarcinoma  of  the
bladder.
4Seventy  five  percent  of  the  urachal
adenocarcinomas are seen in men.
4In our case it was a
female  patient  aged  57  yrs.  These  cases  have  been
reported in patients aged 4months to more than 80yrs
4.
Common symptoms are irrita tive voiding, discharge
of mucous like material and gross hematuria. In our
case patient came with chief complaints of hematuria
with blood clots. Urachal adenocarcinomas have poor
prognosis when compared to bladder cancer because
the lesion arises outside the bladder, where it does not
cause any symptoms.
5
Gore et al
6 described the clinicopathological criteria to
distinguish  urachal  adenocarcinoma  from  bladder
cancer or metastasis:
1)  Sharp  demarcation  between  tumour  and  intact
urothelium.
2) Cystitis cystica or glandularis is absent.
3)  Growth  in  the bladder  with  extension  to  bladder
dome or anterior wall.
Urachal malignant epithelial tumours have a glandular
pattern,  but Paner. GP  et  al
7 have  described  urachal
carcinoma of the nonglandular type in their study with
rare  histologic  types  as  squamous  cell  and  other
carcinomas.  However  the  criteria  for  diagnosing
urachal  adenocarcinoma  cannot  be  applied  to  non
glandular tumours.
Urachaladenocarcinomas have  several
morphologicalpatterns,  including enteric,  mucinous,
signet ring cell types and not otherwise specified, the
clinical significance of these morphological types are
not  known.  Bissonnetteetal
8 have  suggested  larger
studies,  to  know  the clinical  implications  of  the
different morphological types of urachal carcinoma.
Several  staging  systems  are  proposed.  The  most
commonly  used  ones  are  Sheldon  and  the  Mayo
staging system .Sheldon staging is as follows Stage I-
no  invasion  beyond  the  urachal  mucosa;  Stage  II-
invasion  confined  to  the  urachus;  StageIII- local
extension to the bladder, abdominal wall, and viscera
other  than  the  bladder;  and  Stage  IV- metastasis  to
regional lymph nodes and distant sites. The Mayo and
Sheldon  staging  systems  were  highly  correlated  (p
value<.001) in a study done by Ashley et al
5.
Piégay F et al stated that these tumors can recur and
most  commonly  metastasize  to  lymphnodes,
retroperitoneum lungs, liver and bone.
9
Ceylan et al
10concluded in their study that the roles of
radiotherapy  and  chemotherapy  in  the  treatment  of
urachal carcinoma are not clear. Usually, patients with
nodal  involvement,  positive  surgical  margin  and
metastasis are treated with adjuvant chemotherapy.
CONCLUSION
Signet  ring  cell  adenocarcinoma  of  urachal  cyst  is
extremely  rare.  These  tumors  have  worst  prognosis
because of late presentation. The 5 yr survival depends
mainly on the clearance of surgical margins.
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